The studies, which were published in the British Journal of Pharmacology, Frontiers in Pharmacology, as well as the International Journal of Molecular Studies, found that when mice were given a toxin meant to trigger a lethal immunity response leading to Acute Respiratory Distress Syndrome (ARDS) followed by the mice being given THC, they were spared ARDS’ deadly symptoms and they actually found an increase in beneficial lung bacteria.